Skip to content

INOZYME PHARMA, INC.: filings

Every INOZYME PHARMA, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 20 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2025-05-14fiscal Q1 202538770000950170-25-070921
10-K2025-03-10fiscal FY 202444880000950170-25-035940
10-Q2024-11-05fiscal Q3 2024381110000950170-24-121090
10-Q2024-08-06fiscal Q2 2024381070000950170-24-091230
10-Q2024-05-07fiscal Q1 202436740000950170-24-053981
10-K2024-03-12fiscal FY 202344890000950170-24-029673
10-Q2023-11-07fiscal Q3 2023371070000950170-23-059792
10-Q2023-08-08fiscal Q2 2023371040000950170-23-039408
10-Q2023-05-09fiscal Q1 202336750000950170-23-019176
10-K2023-03-22fiscal FY 202244890000950170-23-009053
10-Q2022-11-10fiscal Q3 2022391110000950170-22-024210
10-Q2022-08-15fiscal Q2 2022381070000950170-22-017233
10-Q2022-05-10fiscal Q1 202232670000950170-22-008727
10-K2022-03-15fiscal FY 202135710000950170-22-003789
10-Q2021-11-09fiscal Q3 202132910000950170-21-003776
10-Q2021-08-11fiscal Q2 202133870001564590-21-043215
10-Q2021-05-12fiscal Q1 202133670001564590-21-026724
10-K2021-03-25fiscal FY 202032650001564590-21-015250
10-Q2020-11-12fiscal Q3 202030870001564590-20-053211
10-Q2020-09-03fiscal Q2 202030840001564590-20-042521

Inspect the source

Entity
INOZYME PHARMA, INC. / CIK 0001693011
Captured
2026-09-21T17:24:18.471Z
SEC response SHA-256
ec861933b706c8ee16a37434a4299f3c5965e69abe27f6e0d7f0933b71d72503

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001693011.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))